<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">2855</id>
  <title>T3D2813</title>
  <common-name>Triflupromazine</common-name>
  <description>Triflupromazine is only found in individuals that have used or taken this drug. It is a phenothiazine used as an antipsychotic agent and as an antiemetic. Triflupromazine binds to the dopamine D1 and dopamine D2 receptors and inhibits their activity. The mechanism of the anti-emetic effect is due predominantly to blockage of the dopamine D2 neurotransmitter receptors in the chemoreceptor trigger zone (CTZ) and vomiting centre. Triflupromazine blocks the neurotransmitter dopamine and the vagus nerve in the gastrointestinal tract. Triflupromazine also binds the muscarinic acetylcholine receptors (M1 and M2) and the tryptamine D receptors (5HT&lt;sub&gt;2B&lt;/sub&gt;).</description>
  <cas>146-54-3</cas>
  <pubchem-id>5568</pubchem-id>
  <chemical-formula>C18H19F3N2S</chemical-formula>
  <weight>352.122100</weight>
  <appearance>White powder.</appearance>
  <melting-point></melting-point>
  <boiling-point>176°C  at  7.00E-01 mm Hg</boiling-point>
  <density nil="true"/>
  <solubility>1.80e-03 g/L</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Absorption may be erratic and peak plasma concentrations show large interindividual differences.</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Triflupromazine binds to the dopamine D1 and dopamine D2 receptors and inhibits their activity. The mechanism of the anti-emetic effect is due predominantly to blockage of the dopamine D2 neurotransmitter receptors in the chemoreceptor trigger zone (CTZ) and vomiting centre. Triflupromazine blocks the neurotransmitter dopamine and the vagus nerve in the gastrointestinal tract. Triflupromazine also binds the muscarinic acetylcholine receptors (M1 and M2) and the tryptamine D receptors (5HT&lt;sub&gt;2B&lt;/sub&gt;).</mechanism-of-toxicity>
  <metabolism>Hepatic.</metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>Used mainly in the management of psychoses. Also used to control nausea and vomiting.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms>Symptoms of overdose include agitation, coma, convulsions, difficulty breathing, difficulty swallowing, dry mouth, extreme sleepiness, fever, intestinal blockage, irregular heart rate, low blood pressure, and restlessness.</symptoms>
  <treatment nil="true"/>
  <created-at type="dateTime">2009-07-21T20:27:04Z</created-at>
  <updated-at type="dateTime">2014-12-24T20:25:51Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Triflupromazine</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id></kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>9711</chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Triflupromazine</stitch-id>
  <drugbank-id>DB00508</drugbank-id>
  <pdb-id></pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F</moldb-smiles>
  <moldb-formula>C18H19F3N2S</moldb-formula>
  <moldb-inchi>InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3</moldb-inchi>
  <moldb-inchikey>InChIKey=XSCGXQMFQXDFCW-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">352.417</moldb-average-mass>
  <moldb-mono-mass type="decimal">352.122103923</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp>5.54</logp>
  <hmdb-id>HMDB14650</hmdb-id>
  <chembl-id>CHEMBL570</chembl-id>
  <chemspider-id>5367</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
</compound>
